has expanded its reach by acquiring a 50% equity interest in MSO Metro, LLC, enhancing their management of 50 outpatient physical therapy clinics, mainly in New York. This strategic acquisition ...

New strategic partnership leverages the power of the Dyno platform ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche ...

The move reflects the continuing influence and strategic decisions of the Ziff family within the company. For further insights into GB:TOWN stock, check out TipRanks’ Stock Analysis page.

As a platform built to solve the most critical challenges facing gene therapy developers, Dyno’s industry-leading gene delivery solutions enable Dyno partners to create ever better gene therapies.

New strategic partnership leverages the power ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche will pay Dyno ...

Comprehensive policies that incorporate demography, family planning, and reproductive health can promote higher levels of stability and development, thereby improving the health and livelihood of ...

BEIJING, Oct. 22 (China Economic Net) - A strategic cooperation agreement was signed among Beijing Yuanxin Huibao Technology Co., Ltd., the Pakistan China Business Association, and Nanjing IASO ...

today announced a strategic alliance to enhance the availability of high-quality, manufacture-ready cryopreserved allogeneic leukopaks for cellular therapy research, development, and treatment.